FDA grants full approval to new Alzheimer's drug meant to slow disease

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 86%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

BREAKING: FDA grants full approval of Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility. The move marks the first time that a drug meant to slow the progression of the disease has been granted full regulatory approval.

on Thursday fully approved the Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility.has been granted full regulatory approval. Other approved drugs only target its symptoms.

The treatment could"give people in the early stages of Alzheimer’s more time to maintain their independence and do the things they love," Joanne Pike, president and CEO of the Alzheimer’s Association, said in a statement.How does Leqembi help Alzheimer's patients?that focused on how well patients performed in six categories: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care.

"In real-world terms, this likely means more time for the patient to be living independently, enjoying their hobbies, their friends and having a better quality of life," Wilcock said."Time will tell how much, but the clinical trial did show significant benefit on activities of daily living measures."Others, however, were less rosy about Leqembi's benefits.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 10. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA to grant full approval for Alzheimer's medication LecanemabIf the FDA grants Lecanemab full approval, medical experts say Medicaid and Medicare will likely cover it MORE ⬇️
Source: abc15 - 🏆 263. / 63 Read more »

FDA to make a decision on whether to approve first Alzheimer’s drugThe FDA is set to decide whether it will fully approve the first Alzheimer’s drug to show it could slow the disease’s progression in certain patients. But the decision could also have other implications, including who would get access to it.
Source: wjxt4 - 🏆 246. / 63 Read more »

FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverageLeqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.
Source: CNBC - 🏆 12. / 72 Read more »

Fiona Phillips: How common is early Alzheimer's?We answer the questions you're asking about Alzheimer's disease, which causes dementia.
Source: bbchealth - 🏆 143. / 63 Read more »